EP Patent

EP1061920B1 — Pharmaceutical formulation comprising a 2[[(2-pyridinyl)methyl]sulfinyl]benzimidazole having anti-ulcer activity and a process for the preparation of such formulation

Assigned to Sandoz AS · Expires 2002-06-12 · 24y expired

What this patent protects

Patent listed against Prilosec.

Drugs covered by this patent

Patent Metadata

Patent number
EP1061920B1
Jurisdiction
EP
Classification
—
Expires
2002-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Sandoz AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.